Maryland Emerging Infections Program

马里兰州新发感染计划(MD EIP)是马里兰州各州之间的工作伙伴关系 卫生部门(马里兰州卫生和精神卫生部门，或“DHMH”)，约翰·霍普金斯大学 彭博公共卫生学院(JHSPH)和马里兰大学巴尔的摩医学院 (UMSOM)。马里兰州于1997年成为国家EIP网络成员站点，并在接下来的七年中 几年来，已经发展成为能够进行主动的、以实验室为基础的监测的成熟伙伴关系 利用确定的监测人群，开展与传染病有关的流行病学和实验室研究 活动，并对新出现的传染病威胁作出快速反应。 MD EIP建议继续与疾控中心、其他联邦合作伙伴和其他EIP站点合作，以 减少新出现的感染对公共卫生的影响，并对其作出反应。具体来说，MD EIP将 参与主动细菌核心监测(ABCS)、食源性疾病主动监测网络 (FoodNet)、呼吸道疾病和综合征监测、快速人口调查和人类 基因组学相关活动。除了少数例外，每项活动的集水区将是 整个州。MD EIP还建议在地理信息开发方面发挥领导作用 监视数据可视化的系统和空间分析模型，假设的生成，以及 描述危险因素和病原体的共同分布。MD EIP将继续加强其 通过继续交叉培训EIP员工，快速应对新出现的传染病问题的能力 并加强与其他伙伴的关系(例如公共卫生准备和应对)。各种各样的 还将为感染控制从业者、实验室人员、当地卫生人员提供培训机会 科室工作人员、住院医师和公共卫生研究生。

The Maryland Emerging Infections Program (MD EIP) is a working partnership among Maryland's state health department (the Maryland Department of Health and Mental Hygiene, or"DHMH"), the Johns Hopkins Bloomberg School of Public Health (JHSPH), and the University of Maryland, Baltimore School of Medicine (UMSOM). Maryland became a national EIP network member site in 1997, and over the ensuing seven years, has developed into a mature partnership capable of performing active, laboratory-based surveillance using defined surveillance populations, conducting epidemiologic and laboratory infectious disease-related activities, and responding rapidly to emerging infectious disease threats. The MD EIP proposes to continue its collaboration with CDC, other federal partners, and other EIP sites to asess the public health impact of, and respond to, emerging infections. Specifically, the MD EIP will participate in Active Bacterial Core Surveillance (ABCs), Foodborne Diseases Active Surveillance Network (FoodNet), surveillance for respiratory diseases and syndromes, rapid population surveys, and human genomics-related activities. With few exceptions, the catchment area for each of these activities will be the entire State. The MD EIP also proposes to provide leadership in the development of geographic information systems and spatial analytic models for the visualization of surveillance data, generation of hypotheses, and description of the codistributions of risk factors and pathogens. The MD EIP will continue to enhance its capacity to quickly respond to newly emerging infectious disease issues by continuing to cross-train EIP staff and stengthen relationships with other partners (e.g. public health preparedness and response). A variety of training opportunities will also be provided for infection control practitioners, laboratorians, local health department staff, medical residents, and public health graduate students.